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SUMMARY.-Erythropoiesis during the development of myeloid leukaemia in
mice was studied, using assay ofradio-iron incorporation inblood, exorepopula-
tion and autorepopulation techniques. These tests indicated a certain tendency
of decreasing erythropoiesis during the leukaemic process due to declining
numbers of the normal erythropoietic cell precursors.
THE mechanism of erythropoiesis has been studied in certain murine diseases;
macrocytic anaemia caused by action of mutant alleles at the W locus (Russell and
Bernstein, 1966) and haemolytic anaemia, known to be an auto-immune type, in
NZB/B1 mice (Helyer and Howie, 1958). The pathogenesis of erythropoiesis in
erythroleukaemia (Friend) was also investigated in several laboratories (Mirand
ct al., 1961; Ludwig et al., 1964; Brodsky et al., 1966). In contrast, there has been
nio intensive study concerning the erythropoiesis in mnyeloid leukaemia ofrodents,
except for the Shay chloroleukaemia (acute myeloid type) in rats reported by
Handler et al. (1968) and Handler and Handler (1970). This paper reports the
characteristics of erythropoiesis, i.e. manifestation of anaemia in the late or early
stage ofthe developing myeloid leukaemia in RFM/Un mice, using radio-iron incor-
poration in blood as an indicator.
MATERIALS AND METHODS
The details of the nmice and leukaemia line used have been given elsewhere
(Tanaka and Lajtha, 1969; Tanaka and Craig, 1970). Briefly, the leukaemic cell
line has been maintained at 7 to 10 day intervals by intravenous injections of
105-106 leukaemic spleen cells in suspensions.
Assay of 59Fe incorporation in blood. Suspensions of leukaemic spleen cells
from mice with advanced leukaemia were injected into groups of mice, 105 cells
intravenously. Groups of these mice were then injected daily with 59Fe (0.5 ,uCi
per mouse, intramuscularly) as ferric citrate (average specific activity 20 ,uCi/,ug.).
Twenty-four and 48 hours after iron injections, the animals were killed and 59Fe
concentrations in the blood were determined on 0-2 ml. ofwhole blood by a scintil-
lation counter.
Exorepopulation. This technique was described originally by Hodgson (1962a,
1962b) and estimates the size of haematopoietic stem-cells in normal mice. Its
application to the leukaemia system was described elsewhere (Tanaka, Craig and
Lajtha, 1970). Leukaemic spleen cell suspensions were injected into groups of
mice, 105 cells intravenously. These' "donior" mice were killed daily from day 1 to
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day 12, and appropriate dilutions of the bone marrow or spleen cell suspensions
were injected into total body irradiated (900 rad) " recipient " mice. Seven days
after irradiation andinjection, 59Fe (0.5 tCi per mouse) wasinjected into a group of
recipients intramuscularly. On day 9, i.e. 48 hours after iron injections, 0-2 ml. of
blood was collected and 59Fe uptake was determined.
Autorepopulation.-This technique has been applied to stem-cell recovery after
irradiation (Porteous and Lajtha, 1966). Leukaemic spleen cell suspensions of
appropriate dilutions were injected into groups ofmice as before. Groups ofmice
were irradiated (700 rad) with both femora- or one femur-shielded with 7 mm. long
and 4 mm. thick lead plate (Fig. 1). Seven days later 59Fe was injected, and mice
were killed for assessment ofiron-uptake 48 hours later.
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FIG. 1.-An experimental scheme of the autorepopulation technique applied to leukaemia.
RESULTS
Assay of 59Fe incorporation in blood.-The 48-hour iron-uptake remained at the
normal level of 41% up to day 6 after inoculation of leukaemic cells and then
graduallydeclined to alevel of26%byday 10 (Fig. 2). Similarly, the 24-houriron-
uptake started to decrease around day 6 from the normal level of 32% to 17% by
day 10.
Exorepopulation.-Bone marrow cell grafting: In a group given 106 cells from
donors inoculated with leukaemic cells, iron-uptake started to decline from the
normal level of 15.5% to 8% on day 7 ofthe leukaemia (Fig. 3a). However, from
day 9 ofthe leukaemia onwards, none ofthe treated recipients survived the 9-days
post-treatment required for assaying iron-uptake. In a group given 5 x 105 cells,
iron-uptake decreased after day 8 although the majority ofrecipients were not able
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FIG. 2.- 59Fe uptake (at 24 and 48 hours after iron injections) in peripheral blood of leukaemic
cell-inoculated mice. (Shaded areas represent the normal ranges.)
to survive for 9 days required for assay. In groups given 104 and 105 cells, iron-
uptake virtually remained at the same level throughout the leukaemia develop-
ment, 0.45% and 1.3% respectively.
Spleen cell grafting: In a group given 6 x 106 cells from donors inoculated with
leukaemic cells, iron-uptake decreased to 14% from the normallevel of21% on day
8 ofthe leukaemia (Fig. 3b). As seen inthe bone marrow cell grafting, from day 9
of the leukaemia onwards treated recipients died. In groups given 6 x 105
and 3 x 106 cells, iron-uptake remained the same at the early leukaemic stage,
2.2% and 12.5% respectively. The majority of the recipients in a group given
3 x 106 cells were at too advance a stage by day 9.
Autorepopulation.-One femur-shielded: Four groups of animals were injected
with leukaemic spleen cell suspensions consisting of 6 x 104, 6.8 x 104, 2.5 x 105
and 2-8 x 105 cells. Iron-uptake started to decrease in all on day 7 of the
leukaemia from 4.5% to 2.5% (Fig. 4).
Both femora-shielded: Three groups of animals were injected with leukaemic
53§
617T. TANAKA
20-
15
59Fe
10-
-,
r,
1 2 3 4 5 6 7 8 9 10 11 12
DAYS after INJECTION
FiG. 3a.-59Fe uptake in peripheral blood of irradiated and bone-marrow cell-grafted mice
(exorepopulation).
cells consisting of 6.8 x 104, 8 x 104 and 1-25 x 105 cells. Iron-uptake began to
decline in all on day 7 from 10.5% to 6% by day 9 (Fig. 4).
DISCUSSION
The methods described to assess haematopoiesis during the leukaemia develop-
ment have admittedly several disadvantages, especially for studies involving
malignant cell populations. Exorepopulation: The lowest cell inoculum size for
" proper " iron-uptake, i.e. more than 5% oftotal radio-iron injected, is limited to
about 5 x 104 cells (Hodgson, 1962a, 1962b). This is unquestionably a large
inoculum, particularly in the late stage of any type of leukaemias. With such a
large dose of malignant cells, the treated animals certainly cannot survive for a
sufficient period required for iron-uptake as well as colony assay. In contrast, 102
to 103 cell inoculum sizes are very useful ranges for assessment of leukaemia
colonies, as seen in lymphoma (Bruce and van der Gaag, 1963) or lymphocytic
leukaemia (Wodinsky et al., 1967) or myeloid leukaemia (Tanaka and Lajtha,
1969).
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FIG. 3b. 59Fe uptake in peripheral blood of irradiated and spleen cell-grafted mice (exorepopulation).
(Shaded areas represent the normal ranges and figures cell inoculum sizes.)
Autorepopulation: In experiments with either one femur- or both femora-
shielded, the treated mice were not able to survive beyond day 10 after injections of
the leukaemic cells. It should be remembered that the mice in the day 9 group
were kept for another 9 days for 59Fe assay, i.e. they actually survived a total of
18 days after leukaemic cell injections. This was the longest survival time after
injections with the cell inoculum sizes used. Nevertheless, the autorepopulation
technique, especially with both femora-shielded, was a more ideal measurement of
iron-uptake than exorepopulation. This coincides with the view that " the auto-
repopulation test is a fair picture of the animal's capability for haemopoiesis"
(Lajtha et al., 1969).
Due to the several technical limitations, the erythropoietic response during the
leukaemia development cannot be explored fully up to the very advanced stage.
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FIG. 4.-59Fe uptake inperipheral blood ofleukaemic cell-injected and irradiatedmice with one
femur- or both femora-shielded (autorepopulation). (Shaded areas represent the normal
ranges. The symbols indicate four and three different dilutions of leukaemic spleen cell
suspensions used in one femur- and both femora-shielded mice respectively.)
However, these techniques as a whole do suggest that erythropoiesis decreases
during the leukaemic process owing to a decline in numbers ofthe normal erythro-
poietic cell precursors. This is further elucidated by the response pattern in
numbers of the normal haemopoietic colony formers from the bone marrow and
spleentoanincreasingproportionofthemyeloidleukaemia colony-formersrecover-
ablefromthese organs (Tanaka etal., 1970). Yet, theprogress ofanaemiaisrather
slow, and apparently erythropoiesis is not interfered with until the late stage ofthe
leukaemic process. This may be due to the compensatory erythropoiesis in the
spleen (Handler and Handler, 1970) as well as in the liver. The cause for decreas-
ing erythropoiesis is most likely due to a mechanical factor, i.e. replacement of
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erythropoietic tissue by the proliferating leukaemic mass; a similar mechanism
suggestedinrats (Handler etal., 1968) andreported in man (Wassi and Block, 1961).
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